138 related articles for article (PubMed ID: 27769959)
1. More men with low risk prostate cancer are opting for active surveillance, study finds.
BMJ; 2016 Oct; 355():i5688. PubMed ID: 27769959
[No Abstract] [Full Text] [Related]
2. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
Loeb S; Berglund A; Stattin P
J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
[TBL] [Abstract][Full Text] [Related]
3. Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.
Liu J; Womble PR; Merdan S; Miller DC; Montie JE; Denton BT;
Urology; 2015 Nov; 86(5):901-5. PubMed ID: 26358397
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
5. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
Mader EM; Li HH; Lyons KD; Morley CP; Formica MK; Perrapato SD; Irwin BH; Seigne JD; Hyams ES; Mosher T; Hegel MT; Stewart TM
BMC Urol; 2017 May; 17(1):35. PubMed ID: 28482875
[TBL] [Abstract][Full Text] [Related]
6. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
[TBL] [Abstract][Full Text] [Related]
7. Decision-making processes among men with low-risk prostate cancer: A survey study.
Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
[TBL] [Abstract][Full Text] [Related]
8. The feasibility of expectant management with inner-city men with newly diagnosed localized prostate cancer.
Anai S; Nakamura K; Chang MN; Pendleton J; Yacoub S; Rosser CJ
J Health Care Poor Underserved; 2008 Feb; 19(1):164-70. PubMed ID: 18263992
[TBL] [Abstract][Full Text] [Related]
9. The Mind: Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind?
Reis LO; Carter HB
Int Braz J Urol; 2015; 41(1):10-4. PubMed ID: 25928505
[No Abstract] [Full Text] [Related]
10. Population-based assessment of determining predictors for quality of prostate cancer surveillance.
Chamie K; Williams SB; Hershman DL; Wright JD; Nguyen PL; Hu JC
Cancer; 2015 Dec; 121(23):4150-7. PubMed ID: 26307939
[TBL] [Abstract][Full Text] [Related]
11. Clinical and policy perspectives on the adoption of active surveillance for low-risk prostate cancer.
Frendl DM; Sokoloff MH
Med Care; 2014 Jul; 52(7):576-8. PubMed ID: 24926703
[No Abstract] [Full Text] [Related]
12. Expert panel advocates surveillance for men with low-risk prostate cancer.
Slomski A
JAMA; 2012 Jan; 307(2):133. PubMed ID: 22235075
[No Abstract] [Full Text] [Related]
13. Words of Wisdom. Re: Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
Ehdaie B
Eur Urol; 2015 Jun; 67(6):1188-9. PubMed ID: 25944036
[No Abstract] [Full Text] [Related]
14. [Prostate cancer: To treat or not to treat?].
Mazeron JJ
Bull Cancer; 2017 Jan; 104(1):4-5. PubMed ID: 27894505
[No Abstract] [Full Text] [Related]
15. Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.
Bayliss DR; Duff J; Stricker P; Walker K
Urol Nurs; 2017; 37(1):15-22. PubMed ID: 29240360
[TBL] [Abstract][Full Text] [Related]
16. Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.
Volk RJ; Kinsman GT; Le YC; Swank P; Blumenthal-Barby J; McFall SL; Byrd TL; Mullen PD; Cantor SB
J Health Commun; 2015; 20(9):1014-20. PubMed ID: 26066011
[TBL] [Abstract][Full Text] [Related]
17. Expectant management for men with early stage prostate cancer.
Filson CP; Marks LS; Litwin MS
CA Cancer J Clin; 2015; 65(4):265-82. PubMed ID: 25958817
[TBL] [Abstract][Full Text] [Related]
18. Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing.
Overholser S; Nielsen M; Torkko K; Cwilka D; Weaver B; Shi X; Leach RJ; Hernandez J; Huang T; Thompson IM; Thompson IM
J Urol; 2015 Sep; 194(3):680-4. PubMed ID: 25636657
[TBL] [Abstract][Full Text] [Related]
19. Further support for active surveillance in the management of low-volume, low-grade prostate cancer.
Albertsen P
Eur Urol; 2010 Dec; 58(6):836-7. PubMed ID: 20851512
[No Abstract] [Full Text] [Related]
20. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.
Cary KC; Cowan JE; Sanford M; Shinohara K; Perez N; Chan JM; Meng MV; Carroll PR
Eur Urol; 2014 Aug; 66(2):337-42. PubMed ID: 24035632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
